Prognostic factors in patients with thick cutaneous melanoma (> 4 mm)-Reference-Cited by-同舟云学术

Prognostic factors in patients with thick cutaneous melanoma (> 4 mm)

Published:2002-02-15 Issue:4 Volume:94 Page:1049-1056
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zettersten Elizabeth,Sagebiel Richard W.,Miller James R.,Tallapureddy Sreedhar,Leong Stanley P. L.,Kashani-Sabet Mohammed

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. et al. editors. Malignant melanoma of the skin. In: American Joint Committee on Cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven, 1997: 163-67.

2. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

3. High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

4. High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

5. Malignant Melanoma Practical Considerations Concerning Prophylactic Regional Lymph Node Dissection

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Burden of Thin Melanomas in Tuscany, Italy, 1985–2017: Age- and Sex-Specific Temporal Trends in Incidence and Mortality;Cancers;2024-01-26

2. Age as a prognostic factor in thick and ultrathick melanomas without lymph node metastasis;Journal of the European Academy of Dermatology and Venereology;2020-05-22

3. Malignant Melanoma;Histopathology Reporting;2020

4. Prognosis and Management of Thick and Ultrathick Melanoma;American Journal of Clinical Oncology;2019-09-11

5. Microsatellitosis in Patients with Melanoma;Annals of Surgical Oncology;2018-11-12